See more : ShenZhen WeiYe Decoration Group Co.,LTD (300621.SZ) Income Statement Analysis – Financial Results
Complete financial analysis of Cardlytics, Inc. (CDLX) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Cardlytics, Inc., a leading company in the Advertising Agencies industry within the Communication Services sector.
You may be interested
- Willamette Valley Vineyards, Inc. (WVVIP) Income Statement Analysis – Financial Results
- Shawcor Ltd. (MATR.TO) Income Statement Analysis – Financial Results
- Sanix Incorporated (4651.T) Income Statement Analysis – Financial Results
- Komplett Bank ASA (0EFW.L) Income Statement Analysis – Financial Results
- Organization of Football Prognostics S.A. (OPAP.AT) Income Statement Analysis – Financial Results
Cardlytics, Inc. (CDLX)
About Cardlytics, Inc.
Cardlytics, Inc. operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing. The company was incorporated in 2008 and is headquartered in Atlanta, Georgia.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 309.20M | 298.54M | 267.12M | 186.89M | 210.43M | 150.68M | 130.37M | 112.82M | 77.63M |
| Cost of Revenue | 178.83M | 185.91M | 163.78M | 123.62M | 130.97M | 96.00M | 80.26M | 72.41M | 52.49M |
| Gross Profit | 130.38M | 112.63M | 103.34M | 63.27M | 79.46M | 54.68M | 50.11M | 40.41M | 25.14M |
| Gross Profit Ratio | 42.17% | 37.73% | 38.69% | 33.86% | 37.76% | 36.29% | 38.44% | 35.82% | 32.38% |
| Research & Development | 51.35M | 54.44M | 38.10M | 17.53M | 11.70M | 16.21M | 12.15M | 13.90M | 11.60M |
| General & Administrative | 58.81M | 81.45M | 66.22M | 46.53M | 36.72M | 34.23M | 20.10M | 21.36M | 18.20M |
| Selling & Marketing | 57.43M | 74.75M | 66.00M | 45.31M | 43.83M | 41.88M | 31.93M | 31.26M | 32.78M |
| SG&A | 116.24M | 156.19M | 132.22M | 91.84M | 80.55M | 76.11M | 52.03M | 52.62M | 50.98M |
| Other Expenses | 98.46M | 37.54M | 29.87M | 7.83M | 4.54M | -2.10M | 6.28M | -13.26M | -432.00K |
| Operating Expenses | 266.05M | 248.17M | 200.19M | 117.20M | 96.78M | 95.60M | 67.21M | 70.74M | 64.78M |
| Cost & Expenses | 444.87M | 434.08M | 363.97M | 240.82M | 227.76M | 191.60M | 147.46M | 143.15M | 117.27M |
| Interest Income | 3.85M | 1.44M | 297.00K | 440.00K | 829.00K | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 6.18M | 2.56M | 12.56M | 3.05M | 1.38M | 3.26M | 8.24M | 0.00 | 0.00 |
| Depreciation & Amortization | 29.52M | 43.74M | 33.66M | 12.42M | 7.40M | 3.28M | 3.03M | 4.22M | 2.19M |
| EBITDA | -99.00M | -418.98M | -89.91M | -39.51M | -12.79M | -45.97M | -8.37M | -24.00M | -37.45M |
| EBITDA Ratio | -32.02% | -30.75% | -22.91% | -22.65% | -6.08% | -20.49% | -10.35% | -0.15% | -49.41% |
| Operating Income | -135.67M | -135.54M | -96.85M | -53.92M | -17.33M | -40.92M | -17.10M | -56.23M | -39.64M |
| Operating Income Ratio | -43.88% | -45.40% | -36.26% | -28.85% | -8.23% | -27.15% | -13.12% | -49.84% | -51.06% |
| Total Other Income/Expenses | 968.00K | -8.93M | -13.83M | -1.50M | 181.00K | -12.13M | -2.54M | -19.46M | -1.00M |
| Income Before Tax | -134.70M | -466.71M | -136.43M | -55.42M | -17.14M | -53.04M | -19.64M | -75.70M | -40.64M |
| Income Before Tax Ratio | -43.56% | -156.33% | -51.07% | -29.65% | -8.15% | -35.20% | -15.07% | -67.09% | -52.35% |
| Income Tax Expense | 0.00 | -1.45M | -7.86M | 3.05M | 548.00K | -12.13M | 5.74M | 32.11M | -16.00K |
| Net Income | -134.70M | -465.26M | -128.57M | -58.47M | -17.69M | -53.04M | -19.64M | -75.70M | -40.63M |
| Net Income Ratio | -43.56% | -155.85% | -48.13% | -31.29% | -8.41% | -35.20% | -15.07% | -67.09% | -52.33% |
| EPS | -3.69 | -13.92 | -3.99 | -2.15 | -0.75 | -2.78 | -1.01 | -5.40 | -2.90 |
| EPS Diluted | -3.69 | -13.92 | -3.99 | -2.15 | -0.75 | -2.78 | -1.01 | -5.40 | -2.90 |
| Weighted Avg Shares Out | 36.49M | 33.42M | 32.20M | 27.21M | 23.75M | 19.06M | 19.52M | 14.03M | 14.03M |
| Weighted Avg Shares Out (Dil) | 36.49M | 33.42M | 32.20M | 27.21M | 23.75M | 19.06M | 19.52M | 14.03M | 14.03M |
An Investigation Has Commenced on Behalf of Cardlytics, Inc. Shareholders. Contact Levi & Korsinsky to Discuss your CDLX Losses
NEW YORK, NY / ACCESSWIRE / August 29, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Cardlytics, Inc. ("Cardlytics") (NASDAQ:CDLX) concerning possible violations of federal securities laws. Cardlytics announced its second quarter 2024 financial...
Cardlytics Inc. Is Being Looked At For Potential Securities Law Violations And Investors Are Encouraged To Contact The Schall Law Firm
LOS ANGELES, CA / ACCESSWIRE / August 29, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Cardlytics, Inc. ("Cardlytics" or "the Company") (NASDAQ:CDLX) for violations...
Levi & Korsinsky Reminds Cardlytics Investors of the Ongoing Investigation into Potential Violations of Securities Laws - CDLX
NEW YORK, NY / ACCESSWIRE / August 29, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Cardlytics, Inc. ("Cardlytics") (NASDAQ:CDLX) concerning possible violations of federal securities laws. Cardlytics announced its second quarter 2024 financial...
CDLX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Cardlytics, Inc. and Encourages Clients to Contact the Firm!
NEW YORK, NY / ACCESSWIRE / August 29, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Cardlytics, Inc. ("Cardlytics" or "the Company") (NASDAQ:CDLX). Investors who purchased Cardlytics securities are encouraged to obtain...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cardlytics, Inc. - CDLX
NEW YORK, NY / ACCESSWIRE / August 28, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Cardlytics, Inc. ("Cardlytics" or the "Company") CDLX. [email protected] The investigation concerns whether Cardlytics and certain of its officers and/or directors...
Cardlytics, Inc. (CDLX) Shareholders May Have Been Affected by Fraud - Levi & Korsinsky Investigates
NEW YORK, NY / ACCESSWIRE / August 28, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Cardlytics, Inc. ("Cardlytics") (NASDAQ:CDLX) concerning possible violations of federal securities laws. Cardlytics announced its second quarter 2024 financial...
The Schall Law Firm Is Seeking Shareholders In Cardlytics Inc To Join An Inquiry Into Possible Securities Fraud
LOS ANGELES, CA / ACCESSWIRE / August 28, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Cardlytics, Inc. ("Cardlytics" or "the Company") (NASDAQ:CDLX) for violations...
Cardlytics, Inc. Investigation Ongoing: Contact Levi & Korsinsky to Discuss Your Rights - CDLX
NEW YORK, NY / ACCESSWIRE / August 28, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Cardlytics, Inc. ("Cardlytics") (NASDAQ:CDLX) concerning possible violations of federal securities laws. Cardlytics announced its second quarter 2024 financial...
CDLX SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Cardlytics, Inc. and Encourages Shareholders to Contact the Firm Today!
NEW YORK, NY / ACCESSWIRE / August 28, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Cardlytics, Inc. ("Cardlytics" or "the Company") (NASDAQ:CDLX). Investors who purchased Cardlytics securities are encouraged to obtain...
ATTENTION Cardlytics, Inc. Investors: You May Have Been Affected by Fraud - Contact Levi & Korsinsky to Discuss Your Rights
NEW YORK, NY / ACCESSWIRE / August 27, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Cardlytics, Inc. ("Cardlytics") (NASDAQ:CDLX) concerning possible violations of federal securities laws. Cardlytics announced its second quarter 2024 financial...
Source: https://incomestatements.info
Category: Stock Reports